BioCentury
ARTICLE | Financial News

Advantagene raises $14.2M

September 12, 2016 7:00 AM UTC

Immuno-oncology company Advantagene Inc. (Auburndale, Mass.) raised $14.2 million in a series A round from undisclosed investors. The National Securities Corp. subsidiary of National Holdings Corp. (NASDAQ:NHLD) was the placement agent.

The funding is Advantagene's first significant outside investment since it was founded in 1999, CBO Stephen Rocamboli told BioCentury. Advantagene has subsisted primarily on NIH funding since its inception, Rocamboli said. ...